OTCMKTS:NSTM NovelStem International (NSTM) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 09/5/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsBuy This Stock About NovelStem International Stock (OTCMKTS:NSTM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NSTM alerts:Sign Up Key Stats Today's Range$0.0180▼$0.018050-Day Range$0.02▼$0.0352-Week Range$0.01▼$0.04VolumeN/AAverage Volume2,836 shsMarket Capitalization$843.84 thousandP/E Ratio1.80Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida. Read More Receive NSTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NSTM Stock News HeadlinesNovelStem International Delays Q1 2025 Report FilingMay 15, 2025 | tipranks.comArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and MerchandisingJuly 13, 2023 | finance.yahoo.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for. | Investors Alley (Ad)Glencore InternationalApril 24, 2023 | forbes.comNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-KMarch 31, 2023 | finance.yahoo.comNovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two TherapiesDecember 14, 2022 | finance.yahoo.comNovelStem International Corp. (NSTM)October 20, 2022 | finance.yahoo.comNovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial UpdateOctober 13, 2022 | finance.yahoo.comSee More Headlines NSTM Stock Analysis - Frequently Asked Questions How have NSTM shares performed this year? NovelStem International's stock was trading at $0.0078 on January 1st, 2025. Since then, NSTM shares have increased by 130.8% and is now trading at $0.0180. How were NovelStem International's earnings last quarter? NovelStem International Corp. (OTCMKTS:NSTM) posted its quarterly earnings data on Wednesday, August, 6th. The company reported $0.06 earnings per share for the quarter. How do I buy shares of NovelStem International? Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NovelStem International own? Based on aggregate information from My MarketBeat watchlists, some other companies that NovelStem International investors own include Pure Gold Mining (PGM), Osisko Mining (OBNNF), New Gold (NGD), Pure Gold Mining (LRTNF), Hecla Mining (HL), GSE Systems (GVP) and Granada Gold Mine (GGM). Company Calendar Last Earnings8/06/2025Today9/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryRetail Current SymbolOTCMKTS:NSTM CIK912544 Webwww.novelstem.com Phone410-654-3315Fax561-998-2974Employees15Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.01 Trailing P/E Ratio1.80 Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.23 million Net Margins-26,941.67% Pretax Margin-450.00% Return on EquityN/A Return on Assets-61.08% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$10 thousand Price / Sales84.38 Cash FlowN/A Price / Cash FlowN/A Book Value($0.11) per share Price / Book-0.16Miscellaneous Outstanding Shares46,880,000Free Float40,486,000Market Cap$843.84 thousand OptionableNot Optionable Beta2.28 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:NSTM) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovelStem International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
